|
Date |
Time/Location |
Speaker/Affiliation |
Title |
|
9/30/07 |
5:30 PM
Levin Hall Dining
Room |
William
Moyers
Hazelden Foundation
|
"Broken: My Story of Addiction and
Redemption" |
|
10/12/2007 |
12:00 PM
Pharmacology Conference Room |
Frank Ivy
Carroll, Ph. D.
Director of Organic and Medicinal
Chemistry
Research Triangle Institute
Research
Triangle Park, North Carolina
|
"Development of Selective Kappa Opiod
Receptor Antagonists" |
|
1/11/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Helen K. Sable,
Ph.D.
University
of Illinois at
Urbana-Champaign
Department of Veterinary Bioscience Urbana,
Illinois |
"Developmental PCB Exposure:
Implications for Neuropsychiatric
Conditions: |
|
1/18/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Alexandre
Bonnin, Ph.D.
Department of Pharmacology
Vanderbilt University
Nashville, Tennessee
|
"Serotonin-mediated aspects of
neurodevelopment" |
|
1/23/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Tie-Shan
Tang, Ph.D.
Department of Physiology
University of Texas
Southwest Medical Center
Dallas, Texas
|
"Disturbed Ca2+ signaling and apoptosis
of medium spiny neurons (MSN) in
Huntington's disease" |
|
2/1/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Thomas Arthur
Green, Ph.D.
Assistant Professor
Department
of Pharmacology Toxicology
Virginia Commonwealth University Medical
Center
Richmond, Virginia
|
"Regulation of emotional behavior by CREB
activity in the nucleus accumbens" |
|
2/6/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Vinay
Parikh, Ph.D.
University of Michigan
Ann Arbor, Minnesota
|
"Real time cognitive neurochemistry and
function of forebrain cholinergic systems:
new insights and translational implications" |
|
2/20/2008 |
12:00 PM
Pharmacology Conference Room |
Pharmacology and
Toxicology Faculty Candidate
Michael Bruchas,
Ph.D.
University of Washington
Seattle, Washington
|
"Stress-Induced Dysphoria: A Role for
CRF, Kappa-Opioid, and p38 MAPK Pathways" |
|
2/22/2008 |
12:00 PM
Pharmacology Conference Room |
Toni Shippenberg, Ph.D.
Chief,
Integrative Neuroscience Section
NIDA IRP
Baltimore, MD
|
"Opioid Modulation of Monoamine
Transporters: Implications for
Addiction Treatment" |
|
3/7/2008 |
12:00 PM
Pharmacology Conference Room |
Ronald
Emeson, Ph.D.
Joel G. Hardman
Chair in Pharmacology
Professor of Pharmacology and Molecular Physicology & Biophysics
Director, Vanderbilt Transgenic Mouse/ES
Cell Shared Resource
Deputy Director, Center for Molecular
Neuroscience
Vanderbilt University
|
"Physiologic roles of edited serotonin 2C
receptor isoforms" |
|
10/17/2008 |
12:00 PM
Pharmacology Conference Room |
Nora Volkow,
M.D.
Director
National Institute on Drug Abuse
Bethesda, MD |
|
| |
|
|
|